Key #2 For Successful ePRO Selection In Your Ophthalmology Clinical Trial: Use Your PROs To Power Economic Evaluations

Source: Kayentis

Incorporating an economic evaluation within a trial provides valuable information for clinical decision making and coverage determinations, particularly when the clinical effectiveness of the interventions is similar but might vary in terms of patient-reported ability to read, drive or work. In order to understand the impact of an investigational drug on patients’ quality of life (QoL), and analyze its economic consequences, many trials include utility measures. The utility measures help to define and assign value to health states of interest.  A helpful tool for measuring QoL is the PRO, which is a significant input for cost-effectiveness models. Watch the available video to find out more about the effectiveness of the PRO, specifically in ophthalmology.

Visit the Clinical Leader Technologies page for more information on clinical technology.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader